Technology and health care in an era of limits
著者
書誌事項
Technology and health care in an era of limits
(Medical innovation at the crossroads, v. 3)
National Academy Press, 1992
大学図書館所蔵 全8件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Papers presented at the third Institute of Medicine workshop "The Changing Health Care Economy," held April 18-19, 1991, supported by the Howard Hughes Medical Institute, Pfizer, Inc., and the Health Industry Manufacturers Association
Includes bibliographical references and index
内容説明・目次
内容説明
The U.S. health care system is in a state of flux, and changes currently under way seem capable of exerting sizable effects on medical innovation.
This volume explores how the rapid transition to managed care might affect the rate and direction of medical innovation. The experience with technological change in medicine in other nations whose health care systems have "single-payer" characteristics is thoroughly examined.
Technology and Health Care in an Era of Limits examines how financing and care delivery strategies affect the decisions made by hospital administrators and physicians to adopt medical technologies. It also considers the patient's stake in the changing health care economy and the need for a stronger independent contribution of patients to the choice of technology used in their care.
Finally, the volume explores the impact of changes in the demand for medical technology in pharmaceutical, medical device, and surgical procedure innovation.
Table of Contents
FRONT MATTER
PART I: SETTING THE STAGE
PART II: MANAGING CARE IN THE UNITED STATES
PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
PART IV: IMPLICATIONS FOR PROVIDERS
PART V: IMPLICATIONS FOR PATIENTS
PART VI: IMPLICATIONS FOR INNOVATORS
PART VII: CONCLUDING OBSERVATIONS
APPENDIXES
INDEX
目次
- 1 FRONT MATTER
- 2 PART I: SETTING THE STAGE
- 3 PART II: MANAGING CARE IN THE UNITED STATES
- 4 PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
- 5 PART IV: IMPLICATIONS FOR PROVIDERS
- 6 PART V: IMPLICATIONS FOR PATIENTS
- 7 PART VI: IMPLICATIONS FOR INNOVATORS
- 8 PART VII: CONCLUDING OBSERVATIONS
- 9 APPENDIXES
- 10 INDEX
「Nielsen BookData」 より